Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.

Xue, Yan Feng; Song, Zhiqiang; Zhou, Liya; Zhang, Jianzhong; He, Lihua; Bai, Peng

doi:10.1016/j.dld.2016.01.002

Record: found
Abstract: found
Article: not found

Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.

Author(s): Zhiqiang Song ¹ , Liya Zhou ² , Jianzhong Zhang ³ , Lihua He ³ , Peng Bai ¹ , Yan Xue ¹

Publication date (Electronic): May 2016

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Publisher: Elsevier BV

Keywords: Bismuth, Eradication, Helicobacter pylori, Levofloxacin, Non-bismuth quadruple therapy, Second-line

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The best rescue therapy for Helicobacter pylori (H. pylori) infection following failure of non-bismuth quadruple therapy (NBQT) remains unanswered.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Dig Liver Dis

Title: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Publisher: Elsevier BV

ISSN (Electronic): 1878-3562

ISSN (Print): 1590-8658

Publication date (Electronic): May 2016

Volume: 48

Issue: 5

Affiliations

[1 ] Department of Gastroenterology, Peking University Third Hospital, Beijing, China.

[2 ] Department of Gastroenterology, Peking University Third Hospital, Beijing, China. Electronic address: zhouliya123456@163.com.

[3 ] State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Article

Publisher Item ID: S1590-8658(15)30365-0

DOI: 10.1016/j.dld.2016.01.002

PubMed ID: 26847964

SO-VID: 3f98a83b-5fa0-48f5-8031-8ccb208787b5

History

Keywords: Second-line,Non-bismuth quadruple therapy,Bismuth,Eradication,Helicobacter pylori,Levofloxacin

Data availability:

Keywords: Second-line, Non-bismuth quadruple therapy, Bismuth, Eradication, Helicobacter pylori, Levofloxacin

Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.

Read this article at

Abstract

Related collections

When did Helicobacter first colonise humans?

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 447

Cited by 11